Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| RADX | Radiopharm Theranostics | $14.10 | $9.84 | 230.99% | 16.1M | $40M | $3.50$14.27 |
| KYTX | Kyverna Therapeutics | $11.92 | $3.14 | 35.76% | 5.4M | $385M | $1.78$12.50 |
| ARTV | Artiva Biotherapeutics | $4.36 | $1.06 | 32.12% | 537.3K | $81M | $1.47$11.55 |
| GLSI | Greenwich LifeSciences | $13.48 | $2.75 | 25.58% | 2.3M | $149M | $7.78$14.47 |
| ARBB | Arb Iot Group | $8.44 | $1.20 | 16.57% | 1M | $13M | $3.92$18.60 |
| BDRX | Biodexa Pharmaceuticals Plc | $5.49 | $0.74 | 15.58% | 3.6M | $2.9M | $3.58$92.00 |
| IMNM | Immunome | $22.59 | $3.02 | 15.43% | 1.7M | $1.8B | $5.15$23.00 |
| NOMA | Nomadar | $8.47 | $0.89 | 11.74% | 336 | $115M | $2.00$57.70 |
| RRGB | Red Robin Gourmet Burgers | $4.48 | $0.46 | 11.44% | 98.5K | $72M | $2.50$7.89 |
| PVLA | Palvella Therapeutics | $108.78 | $10.20 | 10.34% | 48.2K | $1.2B | $11.17$112.00 |
Related Articles
Featured Article
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Leo Miller|Aug 29, 2024
Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
Alex Carchidi|Feb 25, 2024
The market's excited for these stocks, but there's no rush to buy them.
Advertisement
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Is Red Robin Gourmet Stock a Buy?
Nicholas Rossolillo|Aug 27, 2020
Before betting on a rebound, know that Red Robin isn't exactly on solid footing.
1-800-Flowers.com Says 2020 Looks Like Everything’s Coming Up Roses
Rich Duprey|Jun 18, 2020
It looks like the florist will have a record-setting end to its fiscal year.
Red Robin's First-Quarter Loss Per Share Is 6 Times Greater Than Analysts Expected
Howard Smith|Jun 10, 2020
But the restaurant chain says sales in reopened locations are exceeding expectations.
Why Some Restaurant Stocks Are Falling Today
Anders Bylund|Jun 9, 2020
Gloomy COVID-19 news took the edge off a sector rally that was inspired by states moving back toward normal business operations -- perhaps a bit too early.
